Alsaidalani, Ashwag A.
García-Solís, Blanca
Bukhari, Esraa
Van Den Rym, Ana
López-Collazo, Eduardo
Sánchez-Ramón, Silvia
Corvillo, Fernando
López-Lera, Alberto
de Andrés, Ana
Martínez-Barricarte, Rubén
Perez de Diego, Rebeca https://orcid.org/0000-0001-8426-8765
Funding for this research was provided by:
Instituto de Salud Carlos III (PI22/00790, PI17/00543)
Fundación para la Investigación del Hospital Universitari La Fe (Ayudas Luis _Alvarez 2022 FIBHULP)
Comunidad de Madrid (PEJD2019-PRE/BMD-16556)
European Society for Immunodeficiencies (ESID Bridge Fellowship)
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R21AI171466, #1R01CA269217-01A1, 1R01AI168210-01A1)
Article History
Received: 22 August 2023
Accepted: 26 October 2023
First Online: 22 December 2023
Declarations
:
: The experimental protocol was approved by the ethics committee of La Paz University Hospital (Madrid, Spain) and King Abdulaziz University Hospital (Jeddah, Saudi Arabia).
: Written informed consent was obtained from the family for participation in this study.
: Written informed consent was obtained from the family for publication in this study.
: The authors declare no competing interests.